Morphosys AG
Records under this name other than the patents Morphosys AG holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 38 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,101,727 | Compositions and Methods of Use for Antibodies of C-Met Formerly held In force · High confidence | In force | High confidence | |
| US 7,879,322 | Compositions and Methods for Use for Antibodies Against Sclerostin Formerly held In force · High confidence | In force | High confidence | |
| US 8,246,953 | Compositions and Methods for Use for Antibodies Against Sclerostin Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,486,661 | Polynucleotides Encoding Antibodies Against Sclerostin and Uses Therefor Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,551,482 | Compositions and Methods for Increasing Muscle Growth Formerly held In force · High confidence | In force | High confidence | |
| US 9,458,240 | Anti-Baffr Antibody Formulations Formerly held In force · High confidence | In force | High confidence | |
| US 9,051,365 | Antibodies That Bind Factor P Formerly held In force · High confidence | In force | High confidence | |
| US 9,988,440 | Compositions Comprising Antibodies Targeting Factor P Formerly held In force · High confidence | In force | High confidence | |
| US 12,054,555 | Anti-Baffr Antibody Formulations and Methods of Use Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,865,237 | Nucleic Acids Encoding Anti-Factor P Antibodies Formerly held In force · High confidence | In force | High confidence |